adenosine diphosphate has been researched along with Parkinson Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, F; Benarroch, EE; Boeve, BF; Bower, J; Camerucci, E; Kim, Y; Knopman, D; Lucien, F; Mielke, MM; Mullan, A; Petersen, RC; Ross, OA; Savica, R; Singer, W; Stang, C; Wszolek, ZK | 1 |
| Chen, Q; Ding, W; Li, S; Liu, J; Ma, L; Zhang, W | 1 |
| Borompokas, N; Bronstein, JM; Hadjigeorgiou, GM; Kanavouras, K; Latsoudis, H; Mastorodemos, V; Papapetropoulos, S; Plaitakis, A; Ritz, B; Skoula, I; Spanaki, C; Xiromerisiou, G; Zaganas, I | 1 |
| Castellani, RJ; Gao, Y; He, X; Liu, W; Perry, G; Smith, MA; Su, B; Wang, X; Zhu, X | 1 |
| Amadoro, G; Atlante, A; Bussani, R; Calissano, P; Capsoni, S; Corsetti, V; Florenzano, F; Mercanti, D | 1 |
| Baudrexel, S; Berg, D; Brockmann, K; Csoti, I; Gasser, T; Hattingen, E; Hauser, AK; Hilker, R; Magerkurth, J; Merten, CD; Pilatus, U; Schulte, C; Srulijes, K | 1 |
| Decker, PA; Dousa, MK; Muenter, MD; Offord, KP; Tyce, GM; Weinshilboum, RM | 1 |
| Kunz, WS; Wallesch, CW; Wiedemann, FR; Winkler-Stuck, K | 1 |
| Andersen, J; Hsu, M; Kumar, J; Srinivas, B; Subramanian, R | 1 |
| Dykens, JA | 1 |
| Hirai, S; Kanai, H; Sotomatsu, A; Tanaka, M | 1 |
11 other study(ies) available for adenosine diphosphate and Parkinson Disease
| Article | Year |
|---|---|
Poly (ADP-Ribose) and α-synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity.
Topics: Adenosine Diphosphate; alpha-Synuclein; Biomarkers; Extracellular Vesicles; Humans; Parkinson Disease; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Ribose; Severity of Illness Index | 2022 |
Identification of ADP/ATP Translocase 1 as a Novel Glycoprotein and Its Association with Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylgalactosamine; Adenine Nucleotide Translocator 1; Adenosine Diphosphate; Animals; Glycoproteins; Mice; Mitochondrial ADP, ATP Translocases; Parkinson Disease; Tandem Mass Spectrometry | 2022 |
Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset.
Topics: Adenosine Diphosphate; Age of Onset; Aged; Biocatalysis; California; Cohort Studies; Demography; Diethylstilbestrol; Female; Glutamate Dehydrogenase; Greece; Guanosine Triphosphate; Humans; Leucine; Male; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Recombinant Proteins | 2010 |
DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Autophagy; Blotting, Western; Cell Line; Cell Survival; Dynamins; Excitatory Amino Acid Antagonists; Fluorescent Antibody Technique; Fluorescent Dyes; Gene Silencing; Genetic Vectors; GTP Phosphohydrolases; Humans; Image Processing, Computer-Assisted; Membrane Potential, Mitochondrial; Microtubule-Associated Proteins; Mitochondria; Mitochondrial Proteins; Neurons; Parkinson Disease; Rats; Reactive Oxygen Species; RNA Interference; Transfection; Tyrosine 3-Monooxygenase | 2011 |
Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
Topics: Adenine Nucleotide Translocator 1; Adenosine Diphosphate; Adenosine Triphosphate; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; Apoptosis; Brain; Cells, Cultured; Cerebellum; Cyclophilins; Disks Large Homolog 4 Protein; Enzyme Inhibitors; Female; Humans; Immunoprecipitation; Intracellular Signaling Peptides and Proteins; Lewy Body Disease; Male; Membrane Proteins; Middle Aged; Mitochondria; Neuroblastoma; Neurons; Parkinson Disease; Peptide Fragments; Rats; Rats, Wistar; Receptors, AMPA; Staurosporine; Subcellular Fractions; Synapses; Synaptosomes; tau Proteins | 2012 |
GBA-associated PD. Neurodegeneration, altered membrane metabolism, and lack of energy failure.
Topics: Adenosine Diphosphate; Adult; Age of Onset; Aged; Algorithms; Aspartic Acid; Brain Chemistry; Choline; Creatine; DNA; Energy Metabolism; Female; Glucosylceramidase; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Membranes; Middle Aged; Mitochondria; Nerve Degeneration; Neurons; Parkinson Disease; Phospholipids; Software | 2012 |
L-DOPA biotransformation: correlations of dosage, erythrocyte catechol O-methyltransferase and platelet SULT1A3 activities with metabolic pathways in Parkinsonian patients.
Topics: Adenosine Diphosphate; Aged; Arylsulfotransferase; Biotransformation; Blood Platelets; Carbidopa; Catechol O-Methyltransferase; Dose-Response Relationship, Drug; Drug Combinations; Erythrocytes; Female; Humans; Levodopa; Male; Methylation; Middle Aged; Parkinson Disease; S-Adenosylmethionine; Sulfates | 2003 |
Effect of coenzyme Q10 on the mitochondrial function of skin fibroblasts from Parkinson patients.
Topics: Adenosine Diphosphate; Adult; Aged; Amobarbital; Antioxidants; Cells, Cultured; Coenzymes; Drug Interactions; Female; Fibroblasts; Glutamic Acid; Humans; Male; Middle Aged; Mitochondria; NAD; Oxygen; Parkinson Disease; Pyruvic Acid; Skin; Ubiquinone | 2004 |
Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aldehydes; Animals; Anti-Bacterial Agents; Blotting, Western; Cell Differentiation; Citrate (si)-Synthase; Dopamine; Dose-Response Relationship, Drug; Doxycycline; Electron Transport Complex I; Glutathione; Hydrogen Peroxide; Ketoglutarate Dehydrogenase Complex; Mitochondria; Multienzyme Complexes; Nitric Oxide; Oxygen; Parkinson Disease; PC12 Cells; Rats; Signal Transduction | 2005 |
Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated CA2+ and Na+: implications for neurodegeneration.
Topics: Adenosine Diphosphate; Animals; Calcium; Cell Hypoxia; Cerebellum; Cerebral Cortex; Electron Spin Resonance Spectroscopy; Electron Transport; Free Radicals; Humans; Hydroxyl Radical; Male; Mitochondria; NAD(P)H Dehydrogenase (Quinone); Nerve Degeneration; Neurons; Nitrogen Oxides; Parkinson Disease; Pyridines; Rats; Rats, Wistar; Sodium; Spin Labels | 1994 |
Dopa and dopamine cause cultured neuronal death in the presence of iron.
Topics: Adenosine Diphosphate; Animals; Antioxidants; Catalase; Cell Membrane; Cell Survival; Cells, Cultured; Deferoxamine; Dihydroxyphenylalanine; Dopamine; Ganglia, Spinal; Intermediate Filament Proteins; Iron; Lipid Peroxidation; Liposomes; Male; Mice; Mice, Inbred BALB C; Neurofilament Proteins; Neurons; Parkinson Disease; Substantia Nigra; Superoxide Dismutase | 1991 |